Avocado fruit (Persea americana Mill) exhibits chemo-protective potentiality against cyclophosphamide induced genotoxicity in human lymphocyte culture

Journal of Experimental Therapeutics and Oncology

Volumn 9, Issue 3, 2011, Pages 221-230

  Paul, Rajkumar ^a,b   Kulkarni, Paresh ^a,c   Ganesh, Narayan ^a  

^a Jawaharlal Nehru Cancer Hospital & Research Centre Bhopal   (India)

^b UNIVERSITY INSTITUTE OF TECHNOLOGY   (India)

^c Bengaluru Medical College and Research Institute   (India)

Author keywords

Anti cancer drug; Avocado fruit; Chemoprotective; Cyclophosphamide; Genotoxicity; Persea americana

Indexed keywords

CYCLOPHOSPHAMIDE; METHANOL; PERSEA AMERICANA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CHROMOSOME ABERRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; FRUIT; HUMAN; HUMAN CELL; LYMPHOCYTE; PHYTOCHEMISTRY; PRIORITY JOURNAL; SOLVENT EXTRACTION;

CELLS, CULTURED; CENTROMERE; CHEMOPREVENTION; CHROMOSOME ABERRATIONS; CYCLOPHOSPHAMIDE; FRUIT; HUMANS; LYMPHOCYTES; METAPHASE; PERSEA; PLANT EXTRACTS;

EID: 84455163162     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Kinzler KW, Bert V. "Introduction". The genetic basis of human cancer (2nd, illustrated, revised ed.). New York: McGraw-Hill, Medical Pub. Division. p. 5. ISBN 978-0-07-137050-9, 2002.
2. Skeel, RT. Handbook of Cancer Chemotherapy, Lippincott Williams & Wilkins, 2003.
3. Schuff-Werner P, Lahr G, Rauschning W, Beyer JH, Golms R, Schrader M, Heyden HW, Nagel GA. Alterations of lymphocyte subpopulations by chemotherapy and chemoimmunotherapy (Thymostimulin) in patients with head and neck cancer. J. Cancer Res and Clin Oncol 111 (1): S122, 1986.
4. Hernandez AM, Fossa SD, Brogger A, Kat A, Skovlund E. Chromosome aberrations after etoposide containing cisplatinbased chemotherapy for malignant germ-cell tumours. Annals of Oncol 11 (7): 897-898, 2000.
5. Rao VK, Knutsen T, Ried T, Wangsa D, Flynn BM, Langham G, Egorin MJ, Cole D, Balis F, Steinberg SM, Bates S, Fojo T. The extent of chromosomal aberrations induced by chemotherapy in non-human primates depends on the schedule of administration. Mutat Res 583 (2): 105-19, 2005. (Pubitemid 40775908)
6. Bielicki L, Voelcker G, Hohorst HJ. Activated cyclophosphamide: An enzyme-mechanism-based suicide inactivator of DNA polymerase/3′-5′ exonuclease. J Cancer Res and Clin Onco 107 (3): 195-198, 2005.
7. Friedman, M. Recent biological and chemical studies of cyclophosphamide. Cancer Chemother. Rep 51: 327-333, 1967.
8. Alarcon, RA, Meienhofer J. Formation of the cytotoxic aldehyde acrolein during in vitro degradation of cyclophosphamide. Nature New Biol 233: 250-252, 1971.
9. Ginsberg AH, Monte WT, Johnson KP. Effect of Cyclophosphamide In Vitro and on Vaccinia Virus Replication in Tissue Culture. J. Virol 21 (1): 277-283, 1977. (Pubitemid 8017674)
10. Kachel DL, Martin WJ. Cyclophosphamide-induced lung toxicity: mechanism of endothelial cell injury. The J. Pharmacol and Exp Therapeut 268 (1): 42-46, 1994. (Pubitemid 24039066)
11. Gurtoo Hira L, Marinello AJ, Struck R, obert F, Paul B, Ronald DP. Studies on the Mechanism of Denaturation of Cytochrome P-450 by Cyclophosphamide and Its Metabolites. The J. Biolog Chem 256 (22): 11691-11701, 1981.
12. Saxena AK, Singh G. Cyclophosphamide-induced chromosomal aberrations and associated congenital malformations in rats. In Vitro Cell & Dev Biol - Animal 34 (10): 751-752, 1998. (Pubitemid 29077057)
13. Fernandes ET, Manivel JC, Reddy PK, Ercole CJ. Cyclophosphamide associated bladder cancer: a highly aggressive disease. Analysis of 12 cases. J. Urol. 156: 1931-1933, 1996. (Pubitemid 26378021)
14. Khan MA, Travis LB, Lynch CF, Soini Y, Hruszkewycz AM, Delgado RM, Holowaty EJ, van Leeuwen FE, Glimelius B, Stovall M, Boice JD Jr, Tarone RE, Bennett WP. p53 mutations in cyclophosphamide-associated bladder cancer. Cancer Epidemiol Biomarkers Prev 7: 397-403, 1998. (Pubitemid 28354128)
15. Tuttle TM, Williams GM, Marshall FF. Evidence for cyclophosphamide- induced transitional cell carcinoma in a renal transplant patient. J Urol. 140: 1009-1011, 1988.
16. Takimoto CH, Calvo E. "Principles of Oncologic Pharmacotherapy" in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) Cancer Management: A Multidisciplinary Approach. 11 ed, 2008.
17. Cyberlipid Center. "FATTY ALCOHOLS: Unsaturated alcohols" 12-29, 2007.
18. Lopez L, Ledesma R, Frati MAC, Hernandez DBC. Monounsaturated fatty acid (avocado) rich diet for mild hypercholesterolemia. Arch Med Res 27(4): 519-23, 1996. (Pubitemid 26411595)
19. Cohen SM, Garland EM, John MS, Okamura T, Smith RA. Acrolein initiates rat urinary bladder carcinogenesis. Cancer Res 52: 3577-3581, 1992.
20. Agrawal RC, Kumar S. Prevention of chromosomal aberration in mouse bone marrow by indole-3-carbinol. Toxico Letters 106 (2-3): 137-141, 1999. (Pubitemid 29257823)
21. Johnson IT. Phytochemicals and cancer. Proceedings of the Nutrition Society 66 (2), 207-215, 2007. (Pubitemid 46684974)
22. Chen H, Morrell PL, Ashworth VE, de la Cruz M, Clegg MT. Tracing the geographic origins of major avocado cultivars. J Hered 100(1): 56-65, 2009.
23. Ojewole, JAO, Amabeoku GJ. Anticonvulsant effect of Persea americana Mill (Lauraceae) (avocado) leaf aqueous extract in mice. Phytother Res 20(8): 696-700, 2006.
24. Gondwe M, Kamadyaapa D, Tufts MA, Chuturgoon AA, Ojewole JA, Musabayane CT. Effects of Persea americana Mill (Lauraceae) (Avocado) ethanolic leaf extract (PAE) on blood glucose and kidney function in streptozotocin (STZ)-induced diabetic rats and on kidney cell lines of the proximal (LLC-PK1) and distal tubules (MDBK). Methods Find Exp Clin Pharmacol 30 (1): 25-35, 2008. (Pubitemid 351397453)
25. Naveh E, Werman MJ, Sabo E, Neeman I. "Defatted avocado pulp reduces body weight and total hepatic fat but increases plasma cholesterol in male rats fed diets with cholesterol". J. Nutr 132 (7): 2015-8, 2002. (Pubitemid 34742893)
26. Sugiyama T, Sato A, Yamashita S. "Synthesis of All Four Stereoisomers of Antibacterial Component of Avocado". Agri and Biol Chem 46(2): 481-485, 1982.
27. Brutti M, Blasco C, Pico Y. Determination of benzoylurea insecticides in food by pressurized liquid extraction and LCMS. J Sep Sci. 33(1):1-10, 2010.
28. Travis LB, Curtis RE, Glimelius B. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Nat Cancer 87: 524-530, 1995.
29. Ding H, Chin YW, Douglas KA, Ambrosio SMD. Chemopreventive characteristics of avocado fruit Phytonutrients: A More Natural. Approach Toward Cancer Prevention. Sem in Cancer Biolog 17(5): 386-394, 2007.
30. Chabner, B, Longo DL. Cancer Chemotherapy and Biotherapy: Principles and Practice. Philadelphia, Lippincott Willians & Wilkins, 2006.
31. Ding H, Han C, Guo D, Chin YW, Ding Y, Kinghorn AD, D'Ambrosio SM. Selective induction of apoptosis of human oral cancer cell lines by avocado extracts via a ROS-mediated mechanism. Nature Cancer 61(3): 348-56, 2009.
32. Simbula G, Columbano A, Ledda-Columbano GM, Sanna L, Deidda M, Diana A. Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells. Apoptosis 12: 113-123, 2007. (Pubitemid 46009508)
33. Butt AJ, Roberts CG, Seawright AA, Oelrichs PB, Macleod JK, Liaw TY, Kavallaris M, Somers-Edgar TJ, Lehrbach GM, Watts CK, Sutherland RL. A novel plant toxin, persin, with in vivo activity in the mammary gland, induces Bim-dependent apoptosis in human breast cancer cells. Mol Cancer Ther 5(9): 2300-9, 2006. (Pubitemid 44530467)
34. Kim OK, Murakami A, Takahashi D, Nakamura Y, Torikai K, Kim HW. An avocado constituent, persenone A, suppresses expression of inducible forms of nitric oxide synthase and cyclooxygenase in macrophages, and hydrogen peroxide generation in mouse skin. Biosci Biotechnol Biochem 64: 2504-7, 2000.
35. Lu QY, Arteaga JR, Zhang Q, Huerta S, Go VL, Heber D. Inhibition of prostate cancer cell growth by an avocado extract: role of lipid-soluble bioactive substances. J Nuture Biochem 16(1): 23-30, 2005. (Pubitemid 40052713)
36. Adeboye JO, Fajonyomi MO, Makinde JM, Taiwo OB. A preliminary study on the hypotensive activity of Persea americana leaf extracts in anaesthetized normotensive rats Fitoterapia 70(1): 15-20, 1999. (Pubitemid 29230099)
37. Brai BIC, Odetola AA, Agomo PU. Effects of Persea americana leaf extracts on body weight and liver lipids in rats fed hyperlipidaemic diet Afri. J Biotech 6 (8): 1007-1011, 2007. (Pubitemid 46684753)
38. Ekor M, Adepoju GKA, Epoyun AA. Protective Effect of the Methanolic Leaf Extract of Persea americana (Avocado) Against Paracetamol-Induced Acute Hepatotoxicity in Rats. Inl J. Pharmaco 2 (4): 416-420, 2006. (Pubitemid 44613208)
39. Ojewole JAO, Kamadyaapa DR, Gondwe MM, Moodley K, Musabayane CT. Cardiovascular effects of Persea americana Mill (Lauraceae) (avocado) aqueous leaf extract in experimental animals. Cardiovascular J. Africa 18(2): 69-76, 2007.
40. Ferrer P, Asensi M, Priego S, Benlloch M, Mena S, Ortega A. Nitric oxide mediates natural polyphenol-induced Bcl-2 down-regulation and activation of cell death in metastatic B16 melanoma. J Biol Chem 282: 2880-90, 2007. (Pubitemid 47086274)
41. Hironori H, Chihoko U, Takanori KK. Acetyl-CoA Carboxylase Inhibitors from Avocado (Persea americana Mill) Fruits. Biosci, Biotech and Biochem 65 (7): 1656-1658, 2001.
42. Nutrition Data.com. Retrieved. "Avocados, raw, California". 12-29, 2007.
43. Goetz P, Malashenko AM, Surkova N. Cyclophosphamideinduced chromosomal aberrations in meiotic cells of male mice. Folia Biol (Praha) 26(5): 289-97, 1980.
44. Ding H, Han C, Guo D, Li J, Ding Y, D'Ambrosio SM Avocado extracts induce apoptosis via reactive oxygen in malignant human oral cells. Fifth AACR Inl Confer on Front in Cancer Prev Res 12-15, 2006.
45. Van Erk MJ, Roepman P, van der Lende TR, Stierum RH, Aarts JM, Van Bladeren PJ. Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancerrelated mechanisms in colon cancer cells in vitro. Eur J Nutr 44: 143-56, 2005. (Pubitemid 40585513)
46. Ding H, Han C, Gibson-D'Ambrosio R, Steele VE, D'Ambrosio SM. Piroxicam selectively inhibits the growth of premalignant and malignant human oral cell lines by limiting their progression through the S phase and reducing the levels of cyclins and AP-1. Int J Cancer 107: 830-6, 2003.